UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82

Diabetologia

Volumn 56, Issue 9, 2013, Pages 1925-1933

  Hayes, A J ^a   Leal, J ^b   Gray, A M ^b   Holman, R R ^c   Clarke, P M ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Complications; Life expectancy; Patient level simulation; Risk modelling; Survival; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INTERMETHOD COMPARISON; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PARAMETRIC TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; UNITED KINGDOM; VALIDATION PROCESS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES;

EID: 84881609353     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2940-y     Document Type: Article

References (26)

1. Clarke PM, Gray AM, Briggs A et al (2004) A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47:1747-1759
2. The Mount Hood 4 Modeling Group (2007) Computer modeling of diabetes and its complications: a report on the fourth Mount Hood Challenge meeting. Diabetes Care 30:1638-1646
3. Mt Hood Challenge Group (2013) Computer modeling of diabetes and its complications: a report on the fifth Mount Hood Challenge meeting. Value Health. doi: 10.1016/j.val.2013.01.002
4. Clarke PM, Gray A, Briggs A, Stevens R, Matthews D, Holman R (2005) On behalf of the UK Prospective Diabetes Study (UKPDS 72). Cost utility analyses of intensive blood-glucose and tight blood-pressure control in type 2 diabetes. Diabetologia 48:868-877
5. Simon J, Gray AM, Clarke P, Wade A, Neil A, Farmer A (2006) Cost-effectiveness of self-monitoring of blood glucose in the management of patients with non-insulin treated type 2 diabetes: economic evaluation of data from the randomised controlled DiGEM trial. Br Med J 336:1177-1180
6. Leal J, Gray AM, Clarke PM (2009) Development of life expectancy tables for people with type 2 diabetes. Eur Hear J 30:834-839
7. Leal J, Hayes AJ, Gray AM, Holman RR, Clarke PM (2012) Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data. Diabetes Care. doi: 10.2337/dc12-1120
8. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB, ISPOR-SMDM Modeling Good Research Practices Task Force (2012) Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Value Health 15:843-850
9. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes (UKPDS 80). N Engl J Med 359:1577-1589
10. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
11. Stehouwer CD, Smulders YM (2006) Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 17:2106-2111
12. Heerspink HJ, Holtkamp FA, de Zeeuw D, Ravid M (2011) Monitoring kidney function and albuminuria in patients with diabetes. Diabetes Care 34(Suppl 2):S325-S329
13. Hillis GS, Woodward M, Rodgers A et al (2012) Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia 55:1283-1290
14. Tong PC, Lee KF, So WY et al (2004) White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27:216-222
15. Go AS, Yang J, Ackerson LM et al (2006) Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 13:2713-2723
16. Nelson CL, Sun JL, Tsiatis AA et al (2008) Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. Statist Med 27:5525-5555
17. Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239-241
18. Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375:481-489
19. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD (2012) ISPOR-SMDM Modeling Good Research Practices Task Force. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health 15:835-842
20. American Diabetes Association Consensus Panel (2004) Guidelines for computer modeling of diabetes and its complications. Diabetes Care 27:2262-2265
21. Clarke PM, Simon J, Cull CA, Holman RR (2006) Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36. Diabetes Care 29:1506-1511
22. Kopec JA, Finès P, Manuel DG et al (2010) Validation of population-based disease simulation models: a review of concepts and methods. BMC Publ Health 10:710
23. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829-841
24. Chan JCN, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129-2140
25. Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 101:671-679
26. Smith-Spangler CM (2012) Transparency and reproducible research in modeling: why we need it and how to get there. Med Decis Making 32:733-743